NCT00066690 2026-02-06
SOFT
ETOP IBCSG Partners Foundation
Phase 3 Completed
Clinical Trials
8 trialsNCT00066703 2026-02-06
TEXT
ETOP IBCSG Partners Foundation
Phase 3 Completed
NCT00066573 2023-08-25
Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast Cancer
Canadian Cancer Trials Group
Phase 3 Completed
NCT00083174 2023-08-25
ExCel
Canadian Cancer Trials Group
Phase 3 Completed
NCT00066586 2020-04-02
Exemestane in Reducing Breast Density in Postmenopausal Women at Risk for Breast Cancer
Canadian Cancer Trials Group
Phase NA Completed
NCT00659373 2016-07-25
Co-SOFT
ETOP IBCSG Partners Foundation
Phase 3 Completed
NCT00002777 2012-07-02
Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Completed
NCT00016432 2011-04-19
Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen
NSABP Foundation Inc
Phase 3 Completed